These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT). Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M Front Immunol; 2018; 9():2153. PubMed ID: 30294330 [TBL] [Abstract][Full Text] [Related]
4. [Busulfan Combined with Cyclophosphamide as the Conditioning Regimen in Patients with Multiple Myeloma Treated by Autolo-gous Hematopoietic Stem Cell Transplantation]. Jin S; Xu Y; Wang PF; Zhou J; Gu B; Li WY; Zhou HF; Fu CC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1618-22. PubMed ID: 26708882 [TBL] [Abstract][Full Text] [Related]
5. [Autologous stem cell transplantation improve the survival of newly diagnosed multiple myeloma patients]. Geng CY; Yang GZ; Wang GR; Wang HJ; Zhou HX; Zhang ZY; Jian Y; Chen WM Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):390-395. PubMed ID: 34218581 [No Abstract] [Full Text] [Related]
6. [Preparation of concentrated grafts of healthy CD34 hematopoietic stem cells and performance of autografts in hematology]. Gorin NC; Lopez M; Douay L; Laporte JP; Lesage S; Stachowiack J; Isnard F; Najman A Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):287-9. PubMed ID: 7687774 [No Abstract] [Full Text] [Related]
7. [Auto-hematopoietic stem cell transplantation for multiple myeloma accompanied with amyloidosis in four limbs]. Song HH; Chen BA; Ding JH; Gao C; Tao YQ; Wang J; Wang J; Zhao G; Sun YY; Cheng J; Bao W Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):770-3. PubMed ID: 19549405 [TBL] [Abstract][Full Text] [Related]
8. Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma. Bhamidipati PK; Fiala MA; Grossman BJ; DiPersio JF; Stockerl-Goldstein K; Gao F; Uy GL; Westervelt P; Schroeder MA; Cashen AF; Abboud CN; Vij R Biol Blood Marrow Transplant; 2017 Dec; 23(12):2065-2069. PubMed ID: 28797783 [TBL] [Abstract][Full Text] [Related]
9. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma. Park S; Jung CW; Jang JH; Kim SJ; Kim WS; Kim K Transpl Infect Dis; 2015 Oct; 17(5):679-87. PubMed ID: 26201517 [TBL] [Abstract][Full Text] [Related]
10. Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus. Bartee E; Chan WM; Moreb JS; Cogle CR; McFadden G Biol Blood Marrow Transplant; 2012 Oct; 18(10):1540-51. PubMed ID: 22516053 [TBL] [Abstract][Full Text] [Related]
11. [Clinical Analysis on the Therapeutic Efficacy of Autologous Hematopoietic Stem Cell Transplantation in 56 Multiple Myeloma Patients]. Wang CY; Xia B; Ning QY; Tian C; Zhao HF; Yang HL; Li MZ; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1396-1402. PubMed ID: 30295257 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation. Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846 [TBL] [Abstract][Full Text] [Related]
13. [Observation of humoral immunity reconstitution and its relationship with infection after autologous hematopoietic stem cell transplantation for patients with multiple myeloma]. Liu JR; Li J; Shang JJ; Zheng D; Gu JL; Zou WY; Xu DR Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):317-22. PubMed ID: 23668204 [TBL] [Abstract][Full Text] [Related]
14. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895 [TBL] [Abstract][Full Text] [Related]
18. Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma. Kang SH; Hwang HS; Park HS; Sun IO; Choi SR; Chung BH; Choi BS; Yang CW; Kim YS; Min CK; Park CW J Korean Med Sci; 2011 Oct; 26(10):1310-5. PubMed ID: 22022183 [TBL] [Abstract][Full Text] [Related]
19. The concentration of CD44 is increased in hematopoietic stem cell grafts of patients with acute myeloid leukemia, plasma cell myeloma, and non-Hodgkin lymphoma. Krause DS; Spitzer TR; Stowell CP Arch Pathol Lab Med; 2010 Jul; 134(7):1033-8. PubMed ID: 20586634 [TBL] [Abstract][Full Text] [Related]
20. [Clinical outcomes of hematopoietic stem cell transplantation for angioimmunoblastic T-cell lymphoma]. Xu LM; Li NN; Wang Z; Wu XX; Dong YJ; Fu XR; Liu Y; Hu LD; Li XF; Wang YN; Wu YM; Ren HY; Zhang MZ; Wang MH; Li YH; Huang WR Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):573-577. PubMed ID: 32397020 [No Abstract] [Full Text] [Related] [Next] [New Search]